SCHEMBL21935360

SCHEMBL21935360

Cc1cc2nc(C(=O)NC3CCOCC3)cc(Cc3ccc(-c4cn(C)nn4)cc3)c2o1

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 7/20 0.54
BRD4 O60885 6/20 0.51
PDE2A O00408 1/20 0.38
PDE11A Q9HCR9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21935771 0.90 CHRM1 (0.55) CHRM1BRD4
SCHEMBL21873633 0.89 CHRM1 (0.57) CHRM1PDE2APDE11A
SCHEMBL31668940 0.89 CHRM1 (0.57) CHRM1PDE2APDE11A
SCHEMBL21935759 0.88 CHRM1 (0.55) CHRM1BRD4
SCHEMBL21935669 0.87 CHRM1 (0.64) CHRM1BRD4
SCHEMBL23672688 0.84 CHRM1 (0.54) CHRM1BRD4PDE2APDE11A
SCHEMBL21873408 0.83 BRD4 (0.38) BRD4
SCHEMBL30428105 0.83 BRD4 (0.38) BRD4
SCHEMBL21935767 0.82 CHRM1 (0.55) CHRM1BRD4
SCHEMBL21935406 0.81 CHRM1 (0.46) CHRM1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643718-B1 HETEROCYCLIC COMPOUND AND ITS USE AS POSITIVE ALLOSTERIC MODULATOR OF THE CHOLINERGIC MUSCARINIC M1 RECEPTOR. TAKEDA PHARMACEUTICALS CO (JP) 2023-07-26 EP disclosed
EP-3643718-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2020-04-29 EP disclosed